Pelago

Pelago provides a virtual clinic for substance use management, combining digital programs, live counseling, CBT, and medication-assisted treatment for alcohol, tobacco, opioid, cannabis, and stimulant use. It sells to employers and health plans as a confidential benefit for members, delivered through an integrated care platform. Founded in 2017 and headquartered in New York, the privately held company closed a Series C round in 2024 and publishes peer-reviewed outcomes on clinical impact and medical cost savings.